新华制药获喷他佐辛上市批准,精麻类药物领域再拓展

财中社
04 Nov 2024

财中社11月4日电新华制药(000756/00719)发布关于喷他佐辛获得化学原料药上市申请批准通知书的公告。公司近日收到国家药品监督管理局核准签发的喷他佐辛的上市申请批准通知书,确认该原料药符合药品注册的有关要求,批准注册。公司是国内第三家通过该原料药审批的企业,标志着公司在精麻类药物领域的进一步发展。喷他佐辛属于精麻类药物,适用于各种疼痛,如癌性疼痛、创伤性疼痛及手术后疼痛等。此药品在国内外已...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10